No photo of Jeffrey Laskin

View Scopus Profile

Jeffrey Laskin

  • 9515 Citations
  • 50 h-Index
1976 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jeffrey Laskin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Macrophages Chemical Compounds
Nitric Oxide Medicine & Life Sciences
Lung Medicine & Life Sciences
Mustard Gas Chemical Compounds
Lung Injury Medicine & Life Sciences
Ozone Medicine & Life Sciences
Irritants Medicine & Life Sciences
Keratinocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2006 2021

Rutgers University Counteract Center Of Excellence

Laskin, J.

National Institutes of Health (NIH)

9/15/06 → 6/30/21

Project: Research project

Mustard Plant
Irritants
Research
Pharmaceutical Preparations
Drug Discovery

Administrative Core

Laskin, J.

National Institutes of Health (NIH)

9/22/16 → 6/30/17

Project: Research project

intellectual property
resources
research and development
research project
candidacy

Education And Training Program

Laskin, J.

National Institutes of Health (NIH)

7/1/14 → 9/21/16

Project: Research project

training program
threat
school
grant
education

Developing Drugs To Mitigate Parathion Intoxication

Laskin, J.

National Institutes of Health (NIH)

9/16/13 → 8/31/18

Project: Research project

Parathion
Paraoxon
Pharmaceutical Preparations
Organophosphates
Cytochrome P-450 Enzyme System

Umdnj/Rutgers University Counteract Research Center Of Excellence

Laskin, J.

National Institutes of Health (NIH)

9/15/06 → 9/21/16

Project: Research project

Irritants
Research
Pharmaceutical Preparations
Pharmaceutical Chemistry
Pharmacology

Research Output 1976 2019

Cannabinoid Receptor CB2
Trophoblasts
Down-Regulation
Cyclic AMP Response Element-Binding Protein
Messenger RNA

Anandamide down-regulates placental transporter expression through CB2 receptor-mediated inhibition of cAMP synthesis

Szilagyi, J. T., Composto-Wahler, G. M., Joseph, L. B., Wang, B., Rosen, T., Laskin, J. & Aleksunes, L., Mar 1 2019, In : Pharmacological Research. 141, p. 331-342 12 p.

Research output: Contribution to journal › Article

Cannabinoid Receptor CB2
Trophoblasts
Down-Regulation
Cyclic AMP Response Element-Binding Protein
Messenger RNA

Hydroxyl Radicals in E-Cigarette Vapor and E-Vapor Oxidative Potentials under Different Vaping Patterns

Son, Y., Mishin, V., Laskin, J., Mainelis, G., Wackowski, O., Delnevo, C., Schwander, S., Khlystov, A., Samburova, V. & Meng, Q., Jun 17 2019, In : Chemical Research in Toxicology. 32, 6, p. 1087-1095 9 p.

Research output: Contribution to journal › Article

Tobacco Products
Hydroxyl Radical
Vapors
Vegetables
Glycerol

Phototoxicity of 7-oxycoumarins with keratinocytes in culture

Guillon, C., Jan, Y. H., Heck, D. E., Mariano, T. M., Rapp, R. D., Jetter, M., Kardos, K., Whittemore, M., Akyea, E., Jabin, I., Laskin, J. & Heindel, N. D., Aug 1 2019, In : Bioorganic Chemistry. 89, 103014.

Research output: Contribution to journal › Article

Phototoxic Dermatitis
Keratinocytes
Coumarins
Light
Growth

Placental BCRP/ABCG2 Transporter Prevents Fetal Exposure to the Estrogenic Mycotoxin Zearalenone

Szilagyi, J. T., Gorczyca, L., Brinker, A., Buckley, B., Laskin, J. & Aleksunes, L., Apr 1 2019, In : Toxicological Sciences. 168, 2, p. 394-404 11 p.

Research output: Contribution to journal › Article

Zearalenone
Mycotoxins
Breast Neoplasms
Placenta
Proteins